A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study

Brown, 1990, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B, N Engl J Med, 323, 1289, 10.1056/NEJM199011083231901 Blankenhorn, 1993, Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). The MARS Research Group, Ann Intern Med, 119, 969, 10.7326/0003-4819-119-10-199311150-00002 1994, Lancet, 344, 633, 10.1016/S0140-6736(94)92082-6 1994, Lancet, 344, 762 Pitt, 1995, Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events. PLAC I investigation, J Am Coll Cardiol, 26, 1133, 10.1016/0735-1097(95)00301-0 Waters, 1994, Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography, Circulation, 89, 959, 10.1161/01.CIR.89.3.959 Watts, 1992, Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Athertosclerosis Regression Study (STARS), Lancet, 339, 563, 10.1016/0140-6736(92)90863-X Jukema, 1995, Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels, Circulation, 91, 2528, 10.1161/01.CIR.91.10.2528 Sacks, 1994, Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients, Lancet, 344, 1182, 10.1016/S0140-6736(94)90506-1 Herd, 1997, Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS], Am J Cardiol, 80, 278, 10.1016/S0002-9149(97)00346-9 Mack, 2000, Serial quantitative coronary angiography and coronary events, Am Heart J, 139, 993, 10.1067/mhj.2000.105702 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 Itakura, 1989, Clinical study of MK-733 (simvastatin)-dose range finding study, Rinsho-Iyaku, 5, 2011 Austen, 1975, A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of CAD, Council on Cardiovascular Surgery, American Heart Association, Circulation, 51, 5, 10.1161/01.CIR.51.4.5 de Feyter, 1991, Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials, Circulation, 84, 412, 10.1161/01.CIR.84.1.412 Reiber, 1985, Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms, Circulation, 71, 280, 10.1161/01.CIR.71.2.280 1994, Lancet, 344, 1383 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401 1998, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels, N Engl J Med, 339, 1349, 10.1056/NEJM199811053391902 Downs, 1998, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS, JAMA, 279, 1615, 10.1001/jama.279.20.1615 Teo, 2000, Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT), Circulation, 102, 1748, 10.1161/01.CIR.102.15.1748 Bestehorn, 1997, The effect of simvastatin on progression of coronary artery disease, Eur Heart J, 18, 226, 10.1093/oxfordjournals.eurheartj.a015224 Rubin, 1991, Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature, 353, 265, 10.1038/353265a0 Ballantyne, 1997, Effects of lipid lowering therapy on progression of coronary and carotid artery disease, Curr Opin Lipidol, 8, 354, 10.1097/00041433-199712000-00006 Rossouw, 1995, Lipid-lowering interventions in angiographic trials, Am J Cardiol, 76, 86C, 10.1016/S0002-9149(99)80476-7 Waters, 1993, Prognostic significance of progression of coronary atherosclerosis, Circulation, 87, 1067, 10.1161/01.CIR.87.4.1067 Keys, 1984, The seven countries study: 2,289 deaths in 15 years, Prev Med, 13, 141, 10.1016/0091-7435(84)90047-1 Sekikawa, 2001, Coronary heart disease mortality among men aged 35–44 years by prefecture in Japan in 1995–1999 compared with that among white men aged 35–44 by state in the United States in 1995–1998: Vital statistics data in recent birth cohort, Jpn Circ J, 65, 887, 10.1253/jcj.65.887 Kodama, 1990, Trend of coronary heart disease and its relationship to risk factors in a Japanese population: A 26-year follow-up, Hiroshima/Nagasaki study, Jpn Circ J, 54, 414, 10.1253/jcj.54.414